Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients. [electronic resource]
Producer: 20060601Description: 83-7 p. digitalISSN:- 0302-282X
- Adolescent
- Adult
- Aged
- Antidepressive Agents, Tricyclic -- administration & dosage
- Depressive Disorder, Major -- diagnosis
- Fatigue -- chemically induced
- Female
- Headache -- chemically induced
- Humans
- Injections, Intravenous
- Inpatients
- Male
- Mianserin -- administration & dosage
- Middle Aged
- Mirtazapine
- Nausea -- chemically induced
- Psychiatric Status Rating Scales
- Severity of Illness Index
- Statistics, Nonparametric
- Treatment Outcome
- Vertigo -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.